Responding to emerging COVID-19 variants of concern
Information
Type
Guidance
Regulated products
Medical Devices
Topics
Coronavirus, Health And Social Care
Published
February 2, 2023
Last updated
February 2, 2023
Description
A set of principles for understanding the impact of new variants on antiviral drugs and monoclonal antibodies
Tags
Organization
Country / Region
United Kingdom
License
Open Government Licence 2.0 (United Kingdom)